These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Selective role of an NH2-terminal WxxLF motif for aberrant androgen receptor activation in androgen depletion independent prostate cancer cells. Dehm SM; Regan KM; Schmidt LJ; Tindall DJ Cancer Res; 2007 Oct; 67(20):10067-77. PubMed ID: 17942941 [TBL] [Abstract][Full Text] [Related]
5. The role of the androgen receptor in the development and progression of prostate cancer. Jenster G Semin Oncol; 1999 Aug; 26(4):407-21. PubMed ID: 10482183 [TBL] [Abstract][Full Text] [Related]
6. Key targets of hormonal treatment of prostate cancer. Part 1: the androgen receptor and steroidogenic pathways. Vis AN; Schröder FH BJU Int; 2009 Aug; 104(4):438-48. PubMed ID: 19558559 [TBL] [Abstract][Full Text] [Related]
7. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes. Axlund SD; Lambert JR; Nordeen SK Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772 [TBL] [Abstract][Full Text] [Related]
8. Molecular regulation of androgen action in prostate cancer. Dehm SM; Tindall DJ J Cell Biochem; 2006 Oct; 99(2):333-44. PubMed ID: 16518832 [TBL] [Abstract][Full Text] [Related]
9. The CCAAT enhancer-binding protein-alpha negatively regulates the transactivation of androgen receptor in prostate cancer cells. Chattopadhyay S; Gong EY; Hwang M; Park E; Lee HJ; Hong CY; Choi HS; Cheong JH; Kwon HB; Lee K Mol Endocrinol; 2006 May; 20(5):984-95. PubMed ID: 16455820 [TBL] [Abstract][Full Text] [Related]
10. Androgen receptor signaling and vitamin D receptor action in prostate cancer cells. Murthy S; Agoulnik IU; Weigel NL Prostate; 2005 Sep; 64(4):362-72. PubMed ID: 15754350 [TBL] [Abstract][Full Text] [Related]
11. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells. Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564 [TBL] [Abstract][Full Text] [Related]
12. Androgen receptor down regulation by small interference RNA induces cell growth inhibition in androgen sensitive as well as in androgen independent prostate cancer cells. Hååg P; Bektic J; Bartsch G; Klocker H; Eder IE J Steroid Biochem Mol Biol; 2005 Aug; 96(3-4):251-8. PubMed ID: 15982869 [TBL] [Abstract][Full Text] [Related]
13. Amplification and co-regulators of androgen receptor gene in prostate cancer. Golias Ch; Iliadis I; Peschos D; Charalabopoulos K Exp Oncol; 2009 Mar; 31(1):3-8. PubMed ID: 19300409 [TBL] [Abstract][Full Text] [Related]
16. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy. Burnstein KL J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399 [TBL] [Abstract][Full Text] [Related]
17. The role of the androgen receptor in the development of prostatic hyperplasia and prostate cancer. Chatterjee B Mol Cell Biochem; 2003 Nov; 253(1-2):89-101. PubMed ID: 14619959 [TBL] [Abstract][Full Text] [Related]
18. Regulation of FGF8 expression by the androgen receptor in human prostate cancer. Gnanapragasam VJ; Robson CN; Neal DE; Leung HY Oncogene; 2002 Aug; 21(33):5069-80. PubMed ID: 12140757 [TBL] [Abstract][Full Text] [Related]
19. Steroidogenic enzyme AKR1C3 is a novel androgen receptor-selective coactivator that promotes prostate cancer growth. Yepuru M; Wu Z; Kulkarni A; Yin F; Barrett CM; Kim J; Steiner MS; Miller DD; Dalton JT; Narayanan R Clin Cancer Res; 2013 Oct; 19(20):5613-25. PubMed ID: 23995860 [TBL] [Abstract][Full Text] [Related]